• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

v-sis 转化细胞中细胞内血小板衍生生长因子受体的自分泌刺激。

Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.

作者信息

Keating M T, Williams L T

机构信息

Howard Hughes Medical Institute, San Francisco, CA.

出版信息

Science. 1988 Feb 19;239(4842):914-6. doi: 10.1126/science.2829358.

DOI:10.1126/science.2829358
PMID:2829358
Abstract

Autocrine activation of platelet-derived growth factor (PDGF) receptors is the mechanism of transformation by the v-sis oncogene. Since the addition of PDGF does not transform normal cells, autocrine mechanisms may involve unique pathways of receptor activation. In this study autocrine stimulation of the PDGF receptor was observed in v-sis-transformed normal rat kidney (NRK) cells. In contrast to receptor activation in normal cells, autocrine activation of PDGF receptors in v-sis-transformed cells occurred in intracellular compartments, disrupting receptor processing and diverting receptors and their precursors to a chloroquine-sensitive degradation pathway. These findings show that intracellular activation of receptors by autocrine mechanisms may play a role in cell transformation.

摘要

血小板源性生长因子(PDGF)受体的自分泌激活是v-sis癌基因导致细胞转化的机制。由于添加PDGF并不能使正常细胞发生转化,因此自分泌机制可能涉及受体激活的独特途径。在本研究中,在v-sis转化的正常大鼠肾(NRK)细胞中观察到了PDGF受体的自分泌刺激。与正常细胞中的受体激活不同,v-sis转化细胞中PDGF受体的自分泌激活发生在细胞内区室,破坏了受体加工过程,并使受体及其前体转向对氯喹敏感的降解途径。这些发现表明,自分泌机制导致的受体细胞内激活可能在细胞转化中起作用。

相似文献

1
Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.v-sis 转化细胞中细胞内血小板衍生生长因子受体的自分泌刺激。
Science. 1988 Feb 19;239(4842):914-6. doi: 10.1126/science.2829358.
2
Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.血小板衍生生长因子受体在sis转化细胞中的快速周转及苏拉明的逆转作用。对自分泌转化机制的启示。
J Biol Chem. 1988 Sep 5;263(25):12608-18.
3
Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.阻断猿猴肉瘤病毒转化细胞中的自分泌刺激可逆转血小板衍生生长因子受体的下调。
Proc Natl Acad Sci U S A. 1984 Dec;81(23):7466-70. doi: 10.1073/pnas.81.23.7466.
4
Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.猿猴肉瘤病毒转化细胞中v-sis基因产物的细胞内周转、新型分泌及有丝分裂活性细胞内形式。对细胞内环自分泌转化的意义。
J Biol Chem. 1990 Jan 25;265(3):1665-75.
5
The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.v-sis癌基因产物而非血小板衍生生长因子(PDGF)A同二聚体在细胞内激活PDGFα和β受体并引发细胞转化。
J Biol Chem. 1992 Feb 15;267(5):3289-93.
6
Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.血小板衍生生长因子(PDGF)B和A同二聚体根据细胞的遗传背景转化小鼠成纤维细胞。
J Biol Chem. 1994 Dec 2;269(48):30604-8.
7
Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.膜锚定v-sis蛋白的细胞内滞留消除自分泌信号转导。
J Cell Biol. 1992 Sep;118(5):1057-70. doi: 10.1083/jcb.118.5.1057.
8
Transformation by v-sis occurs by an internal autoactivation mechanism.v-sis 引起的转化通过内部自激活机制发生。
Science. 1989 Sep 29;245(4925):1496-9. doi: 10.1126/science.2551043.
9
Platelet-derived growth factor in human malignancy.
Biofactors. 1992 Apr;3(4):217-27.
10
Reduction in platelet-derived growth factor receptor mRNA in v-src-transformed fibroblasts.v-src转化的成纤维细胞中血小板衍生生长因子受体mRNA的减少。
Biochim Biophys Acta. 1995 Apr 6;1266(1):9-15. doi: 10.1016/0167-4889(94)00232-4.

引用本文的文献

1
Mutations of FLT3 receptor affect its surface glycosylation, intracellular localization, and downstream signaling.FLT3受体的突变会影响其表面糖基化、细胞内定位及下游信号传导。
Leuk Res Rep. 2019 Nov 27;13:100187. doi: 10.1016/j.lrr.2019.100187. eCollection 2020.
2
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.评估环境中低剂量化学混合物暴露的致癌潜力:未来的挑战。
Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S254-96. doi: 10.1093/carcin/bgv039.
3
Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.
基质血小板衍生生长因子受体 α(PDGFRα)在肺癌异种移植瘤中提供了一种独立于肿瘤细胞 PDGFRα 表达的治疗靶点。
Mol Cancer Ther. 2012 Nov;11(11):2473-82. doi: 10.1158/1535-7163.MCT-12-0431. Epub 2012 Aug 28.
4
Autocrine PDGF stimulation in malignancies.肿瘤的自分泌 PDGF 刺激。
Ups J Med Sci. 2012 May;117(2):83-91. doi: 10.3109/03009734.2012.658119.
5
Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1.在生物合成过程中,过早的配体-受体相互作用限制了生长因子中期因子及其受体 LDL 受体相关蛋白 1 的产生。
J Biol Chem. 2011 Mar 11;286(10):8405-8413. doi: 10.1074/jbc.M110.176479. Epub 2011 Jan 5.
6
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.血小板衍生生长因子-DD 靶向治疗通过调节糖原合成酶激酶-3β磷酸化来抑制病理性血管生成。
J Biol Chem. 2010 May 14;285(20):15500-15510. doi: 10.1074/jbc.M110.113787. Epub 2010 Mar 15.
7
Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.由突变型c-KIT驱动的肿瘤形成是由细胞内而非质膜受体信号传导介导的。
Mol Cell Biol. 2007 Jan;27(1):267-82. doi: 10.1128/MCB.01153-06. Epub 2006 Oct 23.
8
Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.酪氨酸磷酸化调节受体酪氨酸激酶的成熟。
Mol Cell Biol. 2005 May;25(9):3690-703. doi: 10.1128/MCB.25.9.3690-3703.2005.
9
PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.血小板源性生长因子C是尤因家族肿瘤中一种由EWS/FLI诱导的转化生长因子。
Oncogene. 2001 Feb 1;20(5):626-33. doi: 10.1038/sj.onc.1204133.
10
Kinase inhibitors in cancer therapy: a look ahead.癌症治疗中的激酶抑制剂:展望未来。
Drugs. 2000 Mar;59(3):435-76. doi: 10.2165/00003495-200059030-00004.